July 6, 2006, La Grange, IL -- Cognis has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry. This news follows the May announcement in which Cognis Nutrition & Health unveiled plans to expand its portfolio of health-enhancing ingredients with omega-3s.
“Now that the ink is dry we are working diligently to fully integrate omega-3s into Cognis’ product mix so we can effectively address the strong interest expressed by customers and prospects,” said Dave Eckert, Vice President, Cognis Nutrition & Health. “This is a high priority for Cognis given the significant demand for this product. The new product line will be delivered with the same superior quality and value-added services as our other products,” Mr. Eckert emphasized.
Omega-3s are polyunsaturated fatty acids backed by decades of science showing benefits for overall health, specifically for the heart, and the brain -- the newest health platform for Cognis. As the world’s largest producer of plant sterols and sterol esters, Cognis provides heart health ingredients for a broad range of functional foods and dietary supplements. Omega-3s are a perfect complement to Cognis’ Vegapure® plant sterols and sterol esters, which have been clinically proven to lower cholesterol. Other leading wellness ingredients include Tonalin® CLA, the #1 selling brand of conjugated linoleic acid, clinically shown to reduce body fat and preserve lean muscle mass. Renowned for its high-quality, natural-source antioxidants including Covitol® natural-source vitamin E, Betatene® natural beta-carotene and Xangold® natural lutein esters, Cognis continues to expand its portfolio of core products as new wellness trends emerge.
Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural-source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals.
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros.
Cognis Nutrition and Health, a business unit of Cognis Group, offers one of the industry’s largest portfolios of natural-source, health-enhancing ingredients for dietary supplements, functional foods, medical nutrition, pharmaceutical and healthcare products. As a global supplier, Cognis partners with industry leaders to provide science-backed products to meet today’s most pressing consumer health needs. Cognis also manufactures emulsifiers, emulsifier-based compounds, and numerous other specialty products for the food industry worldwide.